S. 2069 (112th): Spending Reductions through Innovations in Therapies Agenda Act of 2012

Feb 02, 2012 (112th Congress, 2011–2013)
Died (Referred to Committee)
Barbara Mikulski
Senior Senator from Maryland
Read Text »
Last Updated
Feb 02, 2012
16 pages
Related Bills
H.R. 3891 (identical)

Referred to Committee
Last Action: Feb 02, 2012


This bill was introduced on February 2, 2012, in a previous session of Congress, but was not enacted.

Introduced Feb 02, 2012
Referred to Committee Feb 02, 2012
Full Title

A bill to amend the Public Health Service Act to speed American innovation in research and drug development for the leading causes of death that are the most costly chronic conditions for our Nation, to save American families and the Federal and State governments money, and to help family caregivers.


No summaries available.

7 cosponsors (6D, 1R) (show)

Senate Health, Education, Labor, and Pensions

The committee chair determines whether a bill will move past the committee stage.

Primary Source

THOMAS.gov (The Library of Congress)

GovTrack gets most information from THOMAS, which is updated generally one day after events occur. Activity since the last update may not be reflected here. Data comes via the congress project.


Get a bill status widget for your website »


Click a format for a citation suggestion:


S. stands for Senate bill.

A bill must be passed by both the House and Senate in identical form and then be signed by the president to become law.

The bill’s title was written by its sponsor.

GovTrack’s Bill Summary

We don’t have a summary available yet.

Library of Congress Summary

The summary below was written by the Congressional Research Service, which is a nonpartisan division of the Library of Congress.

Spending Reductions through Innovations in Therapies Agenda Act of 2012 or the SPRINT Act - Amends the Public Health Service Act to direct the Secretary of Health and Human Services (HHS) to establish the Spending Reductions through Innovations in Therapies Program (SPRINT Program) to support development of therapies to reduce spending by federal health care programs for high-cost chronic conditions.
Requires the Program to:
(1) accelerate advanced research and development of such therapies, and
(2) encourage innovation in technologies that may assist such research to reduce the time and cost of therapy development.
Requires the Secretary to select the high-cost chronic conditions that shall be the focus of the Program from conditions among the top 10 leading causes of death designated by the Centers for Disease Control and Prevention (CDC) that have:
(1) the highest current and projected cost to federal health care programs and high long-term care costs;
(2) a likelihood of impairing the ability of an individual to carry out activities of daily living, which can result in the individual becoming dependent on caregivers;
(3) a death rate that has increased and is projected to increase significantly in future years; and
(4) a lack of existing therapies to prevent, control, or cure the condition or delay cognitive decline.
Sets forth the duties of the Secretary, including to: (1) partner with certain nonprofit strategic investment entities, (2) reduce the time and cost barriers between laboratory discoveries and clinical trials for therapies used to treat high-cost chronic conditions, and (3) facilitate innovative and expedited review by the Food and Drug Administration (FDA) of the therapies developed.
Establishes a SPRINT Award Program, under which the Secretary may award contracts or grants to public, nonprofit, early stage companies or growth companies to support advanced research and the development of therapies. Sets forth matching fund requirements. Requires the Secretary to evaluate projects funded.

House Republican Conference Summary

The summary below was written by the House Republican Conference, which is the caucus of Republicans in the House of Representatives.

No summary available.

House Democratic Caucus Summary

The House Democratic Caucus does not provide summaries of bills.

So, yes, we display the House Republican Conference’s summaries when available even if we do not have a Democratic summary available. That’s because we feel it is better to give you as much information as possible, even if we cannot provide every viewpoint.

We’ll be looking for a source of summaries from the other side in the meanwhile.

Use the comment space below for discussion of the merits of S. 2069 (112th) with other GovTrack users.
Your comments are not read by Congressional staff.

comments powered by Disqus